𝔖 Bobbio Scriptorium
✦   LIBER   ✦

304 Anti-angiogenic therapy improves response rate in erlotinib resistant NSCLC xenografts

✍ Scribed by J. Rolff; I. Fichtner; M. Becker; J. Merk


Book ID
119602987
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
45 KB
Volume
8
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.